Brief: Tricida Announces Positive Results From Long-Term Clinical Trial Of TRC101 In Patients With CKD And Metabolic Acidosis

Tricida

28/03/2019 11:23

March 28 (Reuters) - Tricida Inc  TCDA.O :
    * TRICIDA ANNOUNCES POSITIVE RESULTS FROM LONG-TERM CLINICAL
TRIAL
OF TRC101 IN PATIENTS WITH CKD AND METABOLIC ACIDOSIS
    * TRICIDA INC - BLINDED, RANDOMIZED, PLACEBO-CONTROLLED,
40-WEEK
EXTENSION TRIAL, TRCA-301E, MET ITS PRIMARY AND ALL SECONDARY
ENDPOINTS
    * TRICIDA - PATIENTS TREATED WITH TRC101 SHOWED SIGNIFICANT
REDUCTION IN ALL-CAUSE MORTALITY AND PROGRESSION OF CKD VERSUS
PLACEBO WITHIN A YEAR
    * TRICIDA INC SAYS "52-WEEK TRCA-301/301E RESULTS FAR
EXCEEDED OUR
EXPECTATIONS"
    * TRICIDA INC - REMAIN COMMITTED TO SUBMITTING TRC101 NDA
UNDER
ACCELERATED APPROVAL PROGRAM IN SECOND HALF OF 2019

Source text for Eikon:  ID:nBwbN1py5a 
Further company coverage:  TCDA.O 

 ((Reuters.Briefs@thomsonreuters.com;))